Expanding the indication for TAVI: who, why and when?
Session coordinator: P. MacCarthy
- To critically evaluate the data to support the use of TAVI in intermediate risk patients
- To appreciate the outcomes after TAVI and surgical aortic valve replacement in intermediate risk patients
- To identify new and more challenging patient groups who may now benefit from TAVI